Ledger.Open graph →
SEC Form D · Amendment · filed August 24, 2018

ApoGen Biotechnologies, Inc

Offering
$7.6M
Sold
$7.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Thong Le · Seattle, WAExec · DirectorKeno Gutierrez · Seattle, WADirectorAsish Xavier · South San Francisco, CADirectorThong Le · Seattle, WAExec · DirectorKeno Gutierrez · Dover, DEDirectorSteve Gillis · Chicago, ILDirectorJohn J. Santini · Seattle, WADirectorM. J. Erwin · Seattle, WADirectorAsish Xavier · San Francisco, CADirectorIan A. Howes · Seattle, WAExecJoel J. Marcus · Seattle, WADirectorJames J. Sullivan · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗